These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37387123)

  • 21. [To positively deal with the challenges brought by the diagnosis and treatment of systemic light chain amyloidosis].
    Huang XH; Liu ZH
    Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(22):1631-1634. PubMed ID: 34126710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic score of cardiac involvement in AL amyloidosis.
    Nicol M; Baudet M; Brun S; Harel S; Royer B; Vignon M; Lairez O; Lavergne D; Jaccard A; Attias D; Macron L; Gayat E; Cohen-Solal A; Arnulf B; Logeart D
    Eur Heart J Cardiovasc Imaging; 2020 May; 21(5):542-548. PubMed ID: 31292624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 24. [A clinical retrospective analysis of newly diagnosed multiple myeloma patients with systemic light chain amyloidosis].
    Liu Y; You HY; Yan LZ; Jin S; Shang JJ; Shi XL; Yan S; Yao WQ; Wu DP; Liu W; Fu CC
    Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):330-335. PubMed ID: 35680633
    [No Abstract]   [Full Text] [Related]  

  • 25. Performance of
    Awaya T; Minamimoto R; Iwama K; Kubota S; Hotta M; Hirai R; Yamamoto M; Okazaki O; Hara H; Hiroi Y; Hiroe M; Moroi M
    J Nucl Cardiol; 2020 Aug; 27(4):1145-1153. PubMed ID: 31591695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.
    Hasib Sidiqi M; Gertz MA
    Blood Cancer J; 2021 May; 11(5):90. PubMed ID: 33993188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of brain natriuretic peptide - based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis.
    Lilleness B; Doros G; Ruberg FL; Sanchorawala V
    Br J Haematol; 2020 Feb; 188(3):424-427. PubMed ID: 31515797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Clinical Presentation and Management of Systemic Light-Chain Amyloidosis in China.
    Huang XH; Liu ZH
    Kidney Dis (Basel); 2016 Apr; 2(1):1-9. PubMed ID: 27536686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine.
    Palladini G; Russo P; Bosoni T; Verga L; Sarais G; Lavatelli F; Nuvolone M; Obici L; Casarini S; Donadei S; Albertini R; Righetti G; Marini M; Graziani MS; Melzi D'Eril GV; Moratti R; Merlini G
    Clin Chem; 2009 Mar; 55(3):499-504. PubMed ID: 19131635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A real-world study on diagnosis and prognosis of light-chain cardiac amyloidosis in Southern China.
    Wu Z; Li M; Ilyas T; Li W; Zeng M; Li F; Liu Y; Chen M; Chen Y; Zhu Q; Qi N; Liu Q; Tang J
    BMC Cardiovasc Disord; 2021 Sep; 21(1):452. PubMed ID: 34537003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updates in Cardiac Amyloidosis Diagnosis and Treatment.
    Stern LK; Kittleson MM
    Curr Oncol Rep; 2021 Mar; 23(4):47. PubMed ID: 33725199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis.
    Mollee P; Merlini G
    Clin Chem Lab Med; 2016 Jun; 54(6):921-7. PubMed ID: 26812792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retroperitoneal involvement with light chain amyloidosis- case series and literature review.
    Vaxman I; Visram A; Pasvolsky O; Kumar S; Dispenzieri A; Buadi F; Dingli D; Lacy M; Hayman S; Kyle R; Kapoor P; Leung N; Gonsalves W; Kourelis T; Warsame R; Gertz M
    Leuk Lymphoma; 2021 Feb; 62(2):316-322. PubMed ID: 33118418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis.
    Barrett CD; Dobos K; Liedtke M; Tuzovic M; Haddad F; Kobayashi Y; Lafayette R; Fowler MB; Arai S; Schrier S; Witteles RM
    JACC Heart Fail; 2019 Nov; 7(11):958-966. PubMed ID: 31606365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain Amyloidosis.
    Sachchithanantham S; Roussel M; Palladini G; Klersy C; Mahmood S; Venner CP; Gibbs S; Gillmore J; Lachmann H; Hawkins PN; Jaccard A; Merlini G; Wechalekar AD
    J Clin Oncol; 2016 Jun; 34(17):2037-45. PubMed ID: 27114592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Subcutaneous Fat Aspirate and Skin Tru-Cut Biopsy for Amyloid Screening in Patients with Suspected Systemic Amyloidosis.
    Hansen CT; Møller HEH; Rojek AM; Marcussen N; Beck HC; Abildgaard N
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34203841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
    Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
    BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.
    Chitimus DM; Berling E; Garderet L; Venturelli N; Malfatti E; Authier FJ; Nicolas G; Laforêt P; Lefeuvre C
    Eur J Neurol; 2023 Mar; 30(3):745-748. PubMed ID: 36403110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
    Banypersad SM; Sado DM; Flett AS; Gibbs SD; Pinney JH; Maestrini V; Cox AT; Fontana M; Whelan CJ; Wechalekar AD; Hawkins PN; Moon JC
    Circ Cardiovasc Imaging; 2013 Jan; 6(1):34-9. PubMed ID: 23192846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.